{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:11:31Z","timestamp":1780920691681,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":79,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020105","name":"VIVA Foundation for Children with Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001543","name":"Children's Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019579","name":"SingHealth","doi-asserted-by":"publisher","award":["FRFU17PRSMZ1"],"award-info":[{"award-number":["FRFU17PRSMZ1"]}],"id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019579","name":"SingHealth","doi-asserted-by":"publisher","award":["04\/FY2020\/P1\/13-A28"],"award-info":[{"award-number":["04\/FY2020\/P1\/13-A28"]}],"id":[{"id":"10.13039\/100019579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005954","name":"Children\u2019s Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005954","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101191","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T23:06:25Z","timestamp":1774220785000},"page":"101191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Gain of chromosome 1q and MYCN characterize unique subgroups of Asian Wilms tumor patients"],"prefix":"10.1016","volume":"47","author":[{"given":"Meng Kang","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia Teng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0110\u1ed7 Th\u1ecb Ng\u1ecdc","family":"Th\u00f9y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Th\u01b0 \u0110\u1eb7ng Anh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng Hui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isshani","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chik Hong","family":"Kuick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Hwee","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth T.E.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawn D.","family":"Tawng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui Yen","family":"Soh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"York Tien","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siam Wee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Y.M.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor K.M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch\u00ed B\u1ea3o","family":"B\u00f9i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8333-1486","authenticated-orcid":false,"given":"Amos H.P.","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.ctarc.2026.101191_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16173051","article-title":"Inter-ethnic variations in the clinical, pathological, and molecular characteristics of Wilms Tumor","volume":"16","author":"Lim","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101191_bib0002","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1002\/ijc.33147","article-title":"Incidence of childhood renal tumours: an international population-based study","volume":"147","author":"Nakata","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101191_bib0003","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29143","article-title":"Comparative analysis of the clinical characteristics and outcomes of patients with Wilms tumor in the United Kingdom and Japan","volume":"68","author":"Nakata","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"30","key":"10.1016\/j.ctarc.2026.101191_bib0004","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.18.01972","article-title":"Augmentation of therapy for combined loss of heterozygosity 1p and 16q in favorable histology wilms tumor: a Children's oncology Group AREN0532 and AREN0533 study report","volume":"37","author":"Dix","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"39","key":"10.1016\/j.ctarc.2026.101191_bib0005","doi-asserted-by":"crossref","first-page":"66467","DOI":"10.18632\/oncotarget.20191","article-title":"Loss of heterozygosity on chromosome 16q increases relapse risk in Wilms' tumor: a meta-analysis","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101191_bib0006","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4143\/crt.2019.313","article-title":"Loss of heterozygosity at chromosome 16q is a negative prognostic factor in Korean pediatric patients with favorable histology wilms tumor: a report of the Korean Pediatric Hematology Oncology Group (K-PHOG)","volume":"52","author":"Park","year":"2020","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101191_bib0007","first-page":"257","article-title":"[Correlation of 1p\/16q loss of heterozygosity and 1p gain with clinicopathological characteristics and prognosis in Wilms tumor]","volume":"53","author":"Jia","year":"2024","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101191_bib0008","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1097\/MPH.0000000000001696","article-title":"Copy number variations in Wilms tumor: a pilot study from India","volume":"42","author":"Rahiman","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101191_bib0009","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/ijc.31946","article-title":"Clinical, pathological and loss of heterozygosity differences in Wilms tumors between Asian and non-Asian children","volume":"144","author":"Loke","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101191_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization Classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ctarc.2026.101191_bib0011","unstructured":"Administration FaD. Guidance for industry: collection of race and ethnicity data in clinical trials. 2005 Sep."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101191_bib0012","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101191_bib0013","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41588-020-0675-5","article-title":"Subclonal reconstruction of tumors by using machine learning and population genetics","volume":"52","author":"Caravagna","year":"2020","journal-title":"Nat. Genet."},{"issue":"26","key":"10.1016\/j.ctarc.2026.101191_bib0014","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1200\/JCO.2015.66.0001","article-title":"Gain of 1q As a prognostic biomarker in wilms tumors (WTs) treated with preoperative chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 trial: a SIOP Renal tumours Biology Consortium study","volume":"34","author":"Chagtai","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7793","key":"10.1016\/j.ctarc.2026.101191_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101191_bib0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/jamaoncol.2015.5699","article-title":"Diagnostic yield of clinical tumor and germline whole-exome sequencing for children with solid tumors","volume":"2","author":"Parsons","year":"2016","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-021-00308-8","article-title":"Wilms tumour","volume":"7","author":"Spreafico","year":"2021","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101191_bib0018","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jpurol.2020.03.001","article-title":"Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan","volume":"16","author":"Ghafoor","year":"2020","journal-title":"J. Pediatr. Urol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101191_bib0019","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1055\/s-0042-1758567","article-title":"Wilms Tumor in India: a systematic review","volume":"12","author":"Srinivasan","year":"2023","journal-title":"South Asian J. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101191_bib0020","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00383-016-3929-7","article-title":"Anaplastic histology Wilms' tumors registered to the Japan Wilms' Tumor Study Group are less aggressive than that in the National Wilms' Tumor Study 5","volume":"32","author":"Oue","year":"2016","journal-title":"Pediatr. Surg. Int."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101191_bib0021","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41416-020-01102-1","article-title":"Clinically and biologically relevant subgroups of Wilms tumour defined by genomic and epigenomic analyses","volume":"124","author":"Brzezinski","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"19","key":"10.1016\/j.ctarc.2026.101191_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194872","article-title":"Molecular characterization reveals subclasses of 1q gain in intermediate risk wilms tumors","volume":"14","author":"van Belzen","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101191_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.31580","article-title":"The clinical impact of somatic copy number variations in patients with stage IV wilms tumor enrolled in the SIOP 2001 trial and study","volume":"72","author":"Welter","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00441-022-03710-0","article-title":"Restoration of functional PAX3 transcriptional factor enhanced neuronal differentiation in PAX3b isoform-depleted neuroblastoma cells","volume":"391","author":"Muralidharan","year":"2023","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0025","first-page":"vdab043","article-title":"Integrative molecular characterization of pediatric spinal ependymoma: the UK Children's Cancer and Leukaemia Group study","volume":"3","author":"Ahmad","year":"2021","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0026","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/s41467-020-17357-4","article-title":"An OTX2-PAX3 signaling axis regulates group 3 medulloblastoma cell fate","volume":"11","author":"Zagozewski","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101191_bib0027","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2350\/08-05-0466.1","article-title":"PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype","volume":"12","author":"Hueber","year":"2009","journal-title":"Pediatr. Dev. Pathol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101191_bib0028","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/onc.2008.455","article-title":"Canonical WNT signalling determines lineage specificity in Wilms tumour","volume":"28","author":"Fukuzawa","year":"2009","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.ctarc.2026.101191_bib0029","doi-asserted-by":"crossref","DOI":"10.3390\/genes12081281","article-title":"Current epigenetic insights in kidney development","volume":"12","author":"Chan","year":"2021","journal-title":"Genes (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101191_bib0030","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040656","article-title":"Transcriptomic analyses of MYCN-regulated genes in anaplastic wilms' Tumour cell lines reveals oncogenic pathways and potential therapeutic vulnerabilities","volume":"13","author":"Szemes","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"22","key":"10.1016\/j.ctarc.2026.101191_bib0031","first-page":"4173","article-title":"Myc cooperates with \u03b2-catenin to drive gene expression in nephron progenitor cells","volume":"144","author":"Pan","year":"2017","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101191_bib0032","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00467-007-0444-z","article-title":"Pax-2 and N-myc regulate epithelial cell proliferation and apoptosis in a positive autocrine feedback loop","volume":"22","author":"Zhang","year":"2007","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12935-021-02259-2","article-title":"MYCN and MAX alterations in Wilms tumor and identification of novel N-MYC interaction partners as biomarker candidates","volume":"21","author":"Jim\u00e9nez Mart\u00edn","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101191_bib0034","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.18632\/oncotarget.3377","article-title":"Multiple mechanisms of MYCN dysregulation in Wilms tumour","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ctarc.2026.101191_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115305","article-title":"ABCA4 regulates mitophagy in lung adenocarcinoma progression via AMPK pathway by modulating TMSB4X","volume":"163","author":"Zhang","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101191_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132757","article-title":"IRF6 Is involved in the regulation of cell proliferation and transformation in MCF10A cells downstream of notch signaling","volume":"10","author":"Zengin","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101191_bib0037","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/jpp\/rgab009","article-title":"Interferon regulatory factor 6 correlates with the progression of non-small cell lung cancer and can be regulated by miR-320","volume":"73","author":"Liu","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0038","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13048-024-01386-4","article-title":"Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value","volume":"17","author":"Hong","year":"2024","journal-title":"J. Ovarian. Res."},{"key":"10.1016\/j.ctarc.2026.101191_bib0039","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3389\/fendo.2018.00437","article-title":"KISS1\/KISS1R in cancer: friend or foe?","volume":"9","author":"Guzman","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"9407","key":"10.1016\/j.ctarc.2026.101191_bib0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(04)15491-3","article-title":"Epigenetic differences between Wilms' tumours in white and east-Asian children","volume":"363","author":"Fukuzawa","year":"2004","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101191_bib0041","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1349-7006.2012.02269.x","article-title":"Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children","volume":"103","author":"Haruta","year":"2012","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0042","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13073-025-01482-0","article-title":"Distinct pathways for genetic and epigenetic predisposition in familial and bilateral Wilms tumor","volume":"17","author":"Wegert","year":"2025","journal-title":"Genome Med."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101191_bib0043","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41585-025-01055-1","article-title":"Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials","volume":"22","author":"Benedetti","year":"2025","journal-title":"Nat. Rev. Urol."},{"issue":"19","key":"10.1016\/j.ctarc.2026.101191_bib0044","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.21037\/atm-20-6047","article-title":"Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms' tumor","volume":"8","author":"He","year":"2020","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0045","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1038\/s41467-023-43290-3","article-title":"Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumors","volume":"14","author":"Su","year":"2023","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101191_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208936","article-title":"A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: a Children's Oncology Group study","volume":"13","author":"Armstrong","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101191_bib0047","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/pbc.23315","article-title":"TP53 codon 72 polymorphisms in favorable histology Wilms tumors","volume":"59","author":"Cost","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101191_bib0048","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(18)30761-7","article-title":"Childhood cancer burden: a review of global estimates","volume":"20","author":"Bhakta","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ctarc.2026.101191_bib0049","article-title":"Epidemiological transition of urogenital system-related tumors in children and adolescents from the perspective of the global burden of disease","author":"He","year":"2025","journal-title":"Int. J. Surg."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226001024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:45:50Z","timestamp":1780919150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226001024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":49,"alternative-id":["S2468294226001024"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101191","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gain of chromosome 1q and MYCN characterize unique subgroups of Asian Wilms tumor patients","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101191"}}